Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsPharmaceutical Papaverine
PharmaceuticalPharmaceuticalVasodilatorIntracavernosalNon-selective PDE inhibitor

Papaverine

Also known as Papaverine hydrochloride · component of bimix/trimix

Papaverine is a non-selective phosphodiesterase inhibitor and opium-poppy alkaloid used as an intracavernosal vasodilator for erectile dysfunction, usually as part of bimix/trimix injection mixtures alongside phentolamine and alprostadil. It predates the oral PDE5 inhibitors and remains a workhorse of injection therapy for men who fail oral drugs.

01 Overview

Papaverine relaxes vascular and cavernosal smooth muscle through non-selective phosphodiesterase inhibition (raising both cAMP and cGMP) and direct calcium-channel effects. Injected into the corpus cavernosum it produces an erection independent of nerve signalling, which is why it works when oral agents do not. It is rarely used alone now, more often combined with phentolamine (bimix) or with phentolamine and alprostadil (trimix) to improve efficacy and lower each drug's dose.

As an injection therapy it carries the same core risks as alprostadil — priapism and, with repeated use, penile fibrosis — plus a risk of elevated liver enzymes with systemic exposure. It is a prescription compounded therapy, not an oral lifestyle drug.

02 Mechanism

Non-selective phosphodiesterase inhibitor raising cAMP and cGMP, plus direct smooth-muscle relaxant activity, producing NO-independent cavernosal vasodilation.

03 Dosing

TierDoseRouteNotes
Intracavernosal (alone)7.5–60 mgIMInjected into the corpus cavernosum, titrated. Often replaced by lower doses within a mix. (Route intracavernosal; closest enum INTRAMUSCULAR.)

04 Effects

EffectMagnitudeEvidence
Erection independent of PDE5 pathwayProduces erection via direct smooth-muscle relaxation; effective when oral PDE5 inhibitors fail, especially combined in bimix/trimix.high response in mixesClinical

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Elevated liver enzymesTransient rises in transaminases have been reported with papaverine.MildUncommonClinical
Penile fibrosisFibrous nodules or curvature with long-term repeated injection, somewhat more than with alprostadil.ModerateUncommon with repeated useClinical
PriapismProlonged erection >4 h is a urological emergency; papaverine-containing mixes carry a notable priapism risk.SevereUncommon but urgentClinical

07 References

Intracavernous papaverine for erectile dysfunction: efficacy and complicationsJ Urol, 1985
Combination intracavernosal therapy (trimix) reviewPubMed search

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.